OKI-005

Overview

OKI-005 is an orally active inhibitor of Class I HDACs , with primary targeting of HDAC1 , HDAC2 and HDAC3 . OKI-005 is a prodrug of OKI-006 ( HY-144893 ). OKI-005 increases histone acetylation levels, induces apoptosis and inhibits cancer cell proliferation. OKI-005 can be used in research related to triple-negative breast cancer and colorectal cancer .

Application

Products | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Breast Cancer | Products > Disease Areas > Colorectal Cancer | Products > Disease Areas > Digestive System Cancer | Products > Disease Areas > Triple-Negative Breast Cancer | Products > Disease Areas > Cancer | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Epigenetics | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Others | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Drug Resistance | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > HDAC | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Drug Intermediate

Product Information

• Catalog No.: HY-185584
• CAS No.: 1351479-95-2
• Molecular Formula: C29H44N4O6S2
• Molecular Weight: 608.81
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source